@article{54b9bbccc1ca42e1b6dd0a1d541690d3,
title = "An effective chemotherapy-free regimen of ponatinib plus venetoclax for relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia",
author = "Short, \{Nicholas J.\} and Marina Konopleva and Tapan Kadia and Partow Kebriaei and Naval Daver and Xuelin Huang and Lucia Masarova and Robin Cook and Nitin Jain and Elias Jabbour and Hagop Kantarjian and Farhad Ravandi",
note = "Funding Information: This study was supported by Abbvie Pharmaceuticals and MD Anderson Cancer Center, Leukemia Spore Grant P50 CA100632. N.J.S. is supported by the K12 Paul Calabresi Clinical Oncology Scholar Award and the American Society of Hematology Junior Faculty Scholar Award in Clinical Research. ",
year = "2021",
month = jul,
day = "1",
doi = "10.1002/ajh.26175",
language = "English (US)",
volume = "96",
pages = "E229--E232",
journal = "American Journal of Hematology",
issn = "0361-8609",
publisher = "John Wiley and Sons Inc.",
number = "7",
}